Last updated on February 2018

Effect and Efficacy of Xpedition /Alpine Everolimus-eluting Stent for Coronary Atherosclerosis

Brief description of study

The objectives of this study are

1. To establish a prospective registry of the whole patients who received percutaneous coronary intervention with Xience Xpedition/Alpine stent
2. To evaulate the long-term efficacy and safety of coronary stenting with the Xience Xpedition/Alpine stent
3. To compare the long-term efficacy and safety of coronary stenting between the Xience Xpedition/Alpine stent and other contemporary drug-eluting stents which had established their own registry

Detailed Study Description

Secondary endpoints of this study are

Stent thrombosis-24 hours(acute), 30 days(subacute), 1 year(late), every 1 year till 3 years(very-late) after index PCI

Target vessl failure

Composite rate of cardiac death and any MI, 3 years

Composite rate of all death and any MI

Composite rate of all death, any MI, and any repeat revascularization

Compliance and therapy interruptions with prescribed adjunctive antiplatelet therapy